Regulatory submissions are anticipated, with a potential approval timeline of 20262027 if the process proceeds smoothly
doi: 10.1203/00006450-200008000-00016 337 BeaumontABurtonARLemonJBennettBKLloydAVollmer-ConnaU
Springer, Tokyo, pp 161168
Additionally, considering its described effects (and the gng range used) (reviewed [1,2,3,4,5,6,7,8,9,10,11,12,13,14]), we considered it possible that both beneficial effects would appear using two distinctive BPC 157 regimens: either given daily intraperitoneally or given per-orally in drinking water
BPC-157 has been studied for effects on central nervous system recovery, including modulation of serotonin and dopamine receptors, along with protection of blood-brain barrier integrity in rodent stroke and neuroinflammation models [12]